279 related articles for article (PubMed ID: 15801954)
21. Identification of a subtle t(16;19)(p13.3;p13.3) in an infant with multiple congenital abnormalities using a 12-colour multiplex FISH telomere assay, M-TEL.
Brown J; Horsley SW; Jung C; Saracoglu K; Janssen B; Brough M; Daschner M; Beedgen B; Kerkhoffs G; Eils R; Harris PC; Jauch A; Kearney L
Eur J Hum Genet; 2000 Dec; 8(12):903-10. PubMed ID: 11175277
[TBL] [Abstract][Full Text] [Related]
22. Hyperdiploidy and E2A-PBX1 fusion in an adult with t(1;19)+ acute lymphoblastic leukemia: case report and review of the literature.
Hunger SP; Sun T; Boswell AF; Carroll AJ; McGavran L
Genes Chromosomes Cancer; 1997 Dec; 20(4):392-8. PubMed ID: 9408756
[TBL] [Abstract][Full Text] [Related]
23. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
Casagrande G; te Kronnie G; Basso G
Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
[TBL] [Abstract][Full Text] [Related]
24. Molecular investigation of 19p13 in standard and variant translocations: the E12 probe recognizes the 19p13 breakpoint in cases with t(1;19) and acute leukemia other than pre-B immunophenotype.
Yamada T; Craig JM; Hawkins JM; Janossy G; Secker-Walker LM
Leukemia; 1991 Jan; 5(1):36-40. PubMed ID: 1999956
[TBL] [Abstract][Full Text] [Related]
25. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.
Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD
Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801
[TBL] [Abstract][Full Text] [Related]
26. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses.
Izraeli S; Janssen JW; Haas OA; Harbott J; Brok-Simoni F; Walther JU; Kovar H; Henn T; Ludwig WD; Reiter A
Leukemia; 1993 May; 7(5):671-8. PubMed ID: 8483319
[TBL] [Abstract][Full Text] [Related]
27. [E2A gene in t(1;19)-ALL].
Hayashi Y
Nihon Rinsho; 1992 Jun; 50(6):1369-73. PubMed ID: 1355570
[TBL] [Abstract][Full Text] [Related]
28. Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia.
Prima V; Gore L; Caires A; Boomer T; Yoshinari M; Imaizumi M; Varella-Garcia M; Hunger SP
Leukemia; 2005 May; 19(5):806-13. PubMed ID: 15744350
[TBL] [Abstract][Full Text] [Related]
29. Detection of a t(1;22)(q23;q12) translocation leading to an EWSR1-PBX1 fusion gene in a myoepithelioma.
Brandal P; Panagopoulos I; Bjerkehagen B; Gorunova L; Skjeldal S; Micci F; Heim S
Genes Chromosomes Cancer; 2008 Jul; 47(7):558-64. PubMed ID: 18383210
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: characterization and diagnostic utility.
Sang BC; Shi L; Dias P; Liu L; Wei J; Wang ZX; Monell CR; Behm F; Gruenwald S
Blood; 1997 Apr; 89(8):2909-14. PubMed ID: 9108411
[TBL] [Abstract][Full Text] [Related]
31. E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study.
Hunger SP; Fall MZ; Camitta BM; Carroll AJ; Link MP; Lauer SJ; Mahoney DH; Pullen DJ; Shuster JJ; Steuber CP; Cleary ML
Blood; 1998 Feb; 91(3):1021-8. PubMed ID: 9446665
[TBL] [Abstract][Full Text] [Related]
32. A t(12;17)(p13;q12) identifies a distinct TEL rearrangement-negative subtype of precursor-B acute lymphoblastic leukemia.
Reid AG; Seppa L; von der Weid N; Niggli FK; Betts DR
Cancer Genet Cytogenet; 2006 Feb; 165(1):64-9. PubMed ID: 16490598
[TBL] [Abstract][Full Text] [Related]
33. Detection of E2A translocations in leukemias via fluorescence in situ hybridization.
Boomer T; Varella-Garcia M; McGavran L; Meltesen L; Olsen AS; Hunger SP
Leukemia; 2001 Jan; 15(1):95-102. PubMed ID: 11243406
[TBL] [Abstract][Full Text] [Related]
34. Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.
Ribera J; Granada I; Morgades M; González T; Ciudad J; Such E; Calasanz MJ; Mercadal S; Coll R; González-Campos J; Tormo M; García-Cadenas I; Gil C; Cervera M; Barba P; Costa D; Ayala R; Bermúdez A; Orfao A; Ribera JM;
Br J Haematol; 2022 Feb; 196(3):670-675. PubMed ID: 34549416
[TBL] [Abstract][Full Text] [Related]
35. Childhood acute lymphoblastic leukemia with equivocal chromosome markers of the t(1;19) translocation.
Filatov LV; Behm FG; Pui CH; Head DR; Downing JR; Raimondi SC
Genes Chromosomes Cancer; 1995 Jun; 13(2):99-103. PubMed ID: 7542913
[TBL] [Abstract][Full Text] [Related]
36. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
Peter A; Heiden T; Taube T; Körner G; Seeger K
Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
[TBL] [Abstract][Full Text] [Related]
37. A case of mature B-cell ALL with coexistence of t(1;19) and t(14;18) and expression of the E2A/PBX1 fusion gene.
Rowe D; Devaraj PE; Irving JA; Hogarth L; Hall AG; Turner GE
Br J Haematol; 1996 Jul; 94(1):133-5. PubMed ID: 8757523
[TBL] [Abstract][Full Text] [Related]
38. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of TEL/AML1 fusion gene in Brazilian pediatric patients with acute lymphoblastic leukemia.
Zen PR; Lima MC; Coser VM; Silla L; Daudt L; Fernandes MS; Neumann J; Mattevi MS; Ortigara R; Paskulin GA
Cancer Genet Cytogenet; 2004 May; 151(1):68-72. PubMed ID: 15120912
[TBL] [Abstract][Full Text] [Related]
40. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
von Bergh AR; van Drunen E; van Wering ER; van Zutven LJ; Hainmann I; Lönnerholm G; Meijerink JP; Pieters R; Beverloo HB
Genes Chromosomes Cancer; 2006 Aug; 45(8):731-9. PubMed ID: 16646086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
